Celestica, Inc. (CLS)

From the record

Celestica, Inc.'s filings since 2017 show no warning events in the scan: no bankruptcy or receivership notice, no debt default notice, no exchange listing notice, no restatement warning, no auditor change, no material cyber incident and no late-report notice (its current reports).

From the record

Celestica, Inc.'s 4 filed years say what it did: revenue went from $7.3 billion in fiscal 2022 to $12 billion in fiscal 2025, up 19.6% a year; it rose in 3 of 3 years; it never fell from a peak; net income was positive in 4 of 4 of those years (its annual reports).

From the record

Over the 3 fiscal years to 2025-12-31, Celestica, Inc.'s diluted share count shrank about 2.0% a year, and dividends and buybacks returned about 23% of its operating cash flow over 3 years (its filed statements). Its officers and directors filed 166 sales (149 under scheduled 10b5-1 plans) and 0 purchases of their own stock on the open market in the year to 2026-11-05 (their Form 4 filings).

From the record

Return on equity: in the fiscal year ended 2025-12-31, Celestica, Inc. earned about 38 cents of profit for every dollar of shareholders' money, and gross profitability: its products earned about 21 cents per dollar of everything the company owns. Leverage: it owed about 69 cents per dollar of assets, and net share issuance: its share count shrank 2.1% over the year (the filed statements).

From the record

Celestica, Inc.'s standing among 12 graded names in its industry family: revenue of $12 billion in fiscal 2025 ranks in the top 21% by size; a net margin of 6.7% ranks in the top 12%; revenue growth of 19.6% a year over the last 3 filed years ranks in the top 12% (its annual reports).

From the record

Celestica, Inc.'s room to grow, from the newest filed statements (fiscal 2025): cash of $596 million against debt of $751 million leaves -2.1% of its assets as net cash, bottom 46% of its family; cash from operations less capital spending is 3.7% of revenue (top 46%); a gross margin of 12.1% (top 37%); research spending of 1% of revenue (bottom 39%) (its annual report).

From the record

Celestica, Inc.'s growth drivers, from the filed years to fiscal 2025: revenue grew 19.6% a year over the last three filed years against 19.6% over all 4, speeding up (top 27% of its family); the newest year grew 28.5% (top 14%); research spending grew 36.7% a year (top 17%); capital spending grew 22.7% a year (top 14%) (its annual reports). Celestica, Inc. reported 2 lines of business in fiscal 2025: CCS at $9.2 billion (74%), ATS at $3.2 billion (26%); 2 of 2 grew against the year before (its annual report).

From the record

Celestica, Inc.'s newest year against its own record: revenue of $12 billion in fiscal 2025 came in 11.4% above the $11 billion its prior three years' pace pointed to (top 45% of its family); net income of $833 million against a prior three-year average of $284 million (top 15%); a net margin of 6.7% against 3.3% before (top 15%) (its annual reports).